AR and prostate carcinoma: Future studies will also focus on the role of AR in these models, in both the stroma, the cell-autonomous signaling, and tumor-stroma interactions, even in AR-negative prostate cancer cells, which seem to express higher levels of HLA when compared with AR-positive disease (Fig. 7).